BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT01082926-completion@plaintrial.com
DTSTAMP:20261027T192743Z
DTSTART;VALUE=DATE:201309
SUMMARY:Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Ma
 lignant Glioma Using Intratumoral Infusions of GRm13Z40-2\, An Allogeneic 
 CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetak
 ine and HyTK and to be Resistant to Glucocorticoids\, in Combination With 
 Interleukin-2 — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT01082926
URL:https://plaintrial.com/trial/NCT01082926
END:VEVENT
END:VCALENDAR